Callan Family Office LLC Buys Shares of 22,588 Ralliant Corporation $RAL

Posted by Stanley Muller on Aug 24th, 2026

Callan Family Office LLC bought a new position in shares of Ralliant Corporation (NYSE:RAL – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 22,588 shares of the company’s stock, valued at approximately $1,663,000.

Other large investors also recently modified their holdings of the company. Dunhill Financial LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at about $25,000. Global Retirement Partners LLC bought a new stake in shares of Ralliant during the 2nd quarter valued at about $35,000. Danske Bank A S acquired a new stake in Ralliant during the fourth quarter worth about $25,000. Persistent Asset Partners Ltd acquired a new stake in Ralliant during the second quarter worth about $37,000. Finally, Allworth Financial LP lifted its holdings in Ralliant by 134.4% in the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on RAL shares. Wall Street Zen upgraded Ralliant from a “buy” rating to a “strong-buy” rating in a research note on Saturday. BMO Capital Markets initiated coverage on Ralliant in a research report on Monday, July 20th. They set a “market perform” rating and a $78.00 price target on the stock. Royal Bank Of Canada raised their price target on Ralliant from $71.00 to $73.00 and gave the stock a “sector perform” rating in a report on Friday, July 31st. Vertical Research lowered Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective for the company. in a research report on Wednesday, May 27th. Finally, Morgan Stanley upped their price objective on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $75.70.

Read Our Latest Stock Analysis on Ralliant

Ralliant Trading Up 0.2%

Shares of NYSE:RAL opened at $63.72 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75. The company’s 50-day moving average price is $68.94 and its 200 day moving average price is $55.94. The company has a market cap of $7.05 billion, a PE ratio of -5.87, a P/E/G ratio of 2.36 and a beta of 1.61. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $75.41.

Ralliant (NYSE:RAL – Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts anticipate that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Ralliant’s payout ratio is currently -1.84%.

Insider Activity at Ralliant

In related news, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer directly owned 251,967 shares in the company, valued at $18,088,710.93. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the sale, the senior vice president directly owned 31,668 shares in the company, valued at $2,280,096. The trade was a 16.07% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.42% of the company’s stock.

Ralliant Company Profile

(Free Report)

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.